ALIENOR FARMA has a total of 11 patent applications. Its first patent ever was published in 2013. It filed its patents most often in Australia, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are ONCOREX INC, UNIV ERASMUS and ASHKENAZI AVI J.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 2 | |
#2 | United States | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | Chile | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Measuring microorganism processes | |
#5 | Peptides | |
#6 | Analysing materials | |
#7 | Steroids |
# | Name | Total Patents |
---|---|---|
#1 | Piazza Pier Vincenzo | 7 |
#2 | Laroche-Clary Audrey | 5 |
#3 | Houede Nadine | 5 |
#4 | Sciamanna Ilaria | 3 |
#5 | Schumann Gerald | 3 |
#6 | De Luca Chiara | 3 |
#7 | Guadagni Fiorella | 3 |
#8 | Sinibaldi-Vallebona Paola | 3 |
#9 | Spadafora Corrado | 3 |
#10 | Garaci Enrico | 3 |
Publication | Filing date | Title |
---|---|---|
US10214591B1 | Monoclonal antibody to human line-1 ORF2 protein and method for early detection of transforming cells in pre-neoplastic tissues of a human subject | |
BR112015012194A2 | pregnenolone ether-benzyl-3- (4'-substituted) derivatives | |
MX2015009546A | Increased dosage of efavirenz for the treatment of cancer. |